VRDN · Company research
Viridian Therapeutics, Inc. (VRDN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A live call on Viridian's Q3 results is set for 8 a.m. Nov. 4 - Stock Titan | A live call on Viridian's Q3 results is set for 8 a.m. Nov. 4 Stock Titan | View source ↗ | Stock Titan | Oct 20, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics presents 54 percent trial data for VRDN stock - ad-hoc-news.de | Viridian Therapeutics presents 54 percent trial data for VRDN stock ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Oct 20, 2026 | neutral | 0 | 0.6 |
| RBC Capital Keeps Their Buy Rating on Viridian Therapeutics (VRDN) - The Globe and Mail | RBC Capital Keeps Their Buy Rating on Viridian Therapeutics (VRDN) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 10, 2026 | neutral | 0 | 0.6 |
| VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval - Stocktwits | VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| Does Strong Lumvoa Launch Change The Bull Case For Viridian Therapeutics Stock (VRDN)? - Simply Wall Street | Does Strong Lumvoa Launch Change The Bull Case For Viridian Therapeutics Stock (VRDN)? Simply Wall Street | View source ↗ | Simply Wall Street | Sep 24, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics (NasdaqCM:VRDN) Stock Forecast & Analyst Predictions - Simply Wall Street | Viridian Therapeutics (NasdaqCM:VRDN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 22, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics (VRDN) legal chief sells 14,212 shares - Stock Titan | Viridian Therapeutics (VRDN) legal chief sells 14,212 shares Stock Titan | View source ↗ | Stock Titan | Aug 20, 2026 | neutral | 0 | 0.6 |
| Viridian (NASDAQ: VRDN) insider to sell 14,212 shares in August 2026 - Stock Titan | Viridian (NASDAQ: VRDN) insider to sell 14,212 shares in August 2026 Stock Titan | View source ↗ | Stock Titan | Aug 19, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics (VRDN) Stock Rises Despite Deepening Losses And Cash Burn - Simply Wall Street | Viridian Therapeutics (VRDN) Stock Rises Despite Deepening Losses And Cash Burn Simply Wall Street | View source ↗ | Simply Wall Street | Aug 8, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today - Yahoo Finance | Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today Yahoo Finance | View source ↗ | Yahoo Finance | Jul 15, 2026 | neutral | 0 | 0.6 |
| Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone - Yahoo Finance | Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone Yahoo Finance | View source ↗ | Yahoo Finance | Jul 6, 2026 | neutral | 0 | 0.6 |
| VRDN Stock Rises 6.3% in a Week: Here's What You Need to Know - Yahoo Finance | VRDN Stock Rises 6.3% in a Week: Here's What You Need to Know Yahoo Finance | View source ↗ | Yahoo Finance | Jul 1, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M - Yahoo Finance | Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M Yahoo Finance | View source ↗ | Yahoo Finance | May 21, 2026 | neutral | 0 | 0.6 |
| VRDN Stock Records Biggest Single Day Gains In 45 Months – And It’s Not Just Due To A Better-Than-Feared Q1 Loss - Stocktwits | VRDN Stock Records Biggest Single Day Gains In 45 Months – And It’s Not Just Due To A Better-Than-Feared Q1 Loss Stocktwits | View source ↗ | Stocktwits | May 5, 2026 | neutral | 0 | 0.6 |
| VRDN Stock Reassessed As Analysts Cut Targets But Stay Bullish - Timothy Sykes | VRDN Stock Reassessed As Analysts Cut Targets But Stay Bullish Timothy Sykes | View source ↗ | Timothy Sykes | May 5, 2026 | neutral | 0 | 0.6 |
| A Look At Viridian Therapeutics (VRDN) Valuation After A Sharp Multi‑Month Share Price Pullback - Yahoo Finance | A Look At Viridian Therapeutics (VRDN) Valuation After A Sharp Multi‑Month Share Price Pullback Yahoo Finance | View source ↗ | Yahoo Finance | Apr 8, 2026 | neutral | 0 | 0.6 |
| Viridian Therapeutics (VRDN) slides 26.8% as investors digest Phase 3 REVEAL-1 data and reset expectations - Quiver Quantitative | Viridian Therapeutics (VRDN) slides 26.8% as investors digest Phase 3 REVEAL-1 data and reset expectations Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 6, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.